Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03200236 · ClinicalTrials.gov registry record · Phase 3
The Lung Screening, Tobacco and Health Project
A Phase 3 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,114
- Enrollment target
NCT03200236: Completed Phase 3 study, sponsored by Georgetown University.
NCT03200236 is a Phase 3 study that has completed, run by Georgetown University. The registered enrollment target is 1,114 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03200236, a Phase 3 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,114 participants
- Enrollment target
Study Summary
The purpose of this study is to compare intensive telephone counseling (ITC) plus the nicotine patch vs. standard telephone counseling plus the nicotine patch (Usual Care; UC) among current smokers undergoing lung cancer screening. Smoking-related outcomes will be examined at three, six and twelve months post-randomization.
Primary Outcome
Comparison between study arms of 7-day and 30-day point prevalence cessation with biochemical verification. The investigators will also assess quit rates among subgroups (gender, age, nicotine dependence, site).
Interventions
- BEHAVIORAL Intensive Telephone Counseling (8 sessions) with nicotine replacement
- BEHAVIORAL Usual Care: Telephone counseling (3 sessions) with nicotine replacement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,114 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2022-01-30 |
| Phase | Phase 3 |
What the finished NCT03200236 record still lists
NCT03200236 is an interventional study that assigns participants to a tested intervention. Its 1,114 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 2 interventions - of which Intensive Telephone Counseling (8 sessions) with nicotine replacement is the first listed.
NCT03200236 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03200236 about?
NCT03200236 is a clinical study titled "The Lung Screening, Tobacco and Health Project". The purpose of this study is to compare intensive telephone counseling (ITC) plus the nicotine patch vs. standard telephone counseling plus the nicotine patch (Usual Care; UC) among current smokers undergoing lung cancer screening. Smoking-related outcomes will be examined at three, six and twelve m...
What is the current status of trial NCT03200236?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,114 participants. The study started on 2017-05-03. Estimated completion is 2022-01-30.
What interventions are being tested in trial NCT03200236?
The interventions under investigation include: Intensive Telephone Counseling (8 sessions) with nicotine replacement (BEHAVIORAL), Usual Care: Telephone counseling (3 sessions) with nicotine replacement (BEHAVIORAL).
Who is sponsoring clinical trial NCT03200236?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03200236's enrollment target sits among peer trials
1,114 251st of 2000 higher than 1,750 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI